MRC1 and neoplasm: Despite the phenotypic diversity, TAMs often present the M2-like phenotype with the progression of tumor, expressing characteristic markers such as the mannose receptor (CD206) and hemoglobin scavenger receptor (CD163) and correlating with poor prognosis in several solid tumors [8, 14, 15].